Search Results

There are 49887 results for: content related to: How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients?

  1. Potential influence of sevelamer hydrochloride on responsiveness to erythropoiesis-stimulating agents in haemodialysis patients



    Version of Record online : 23 FEB 2012, DOI: 10.1111/j.1440-1797.2011.01545.x

  2. You have free access to this content
    Interventions for erythropoietin-resistant anaemia in dialysis patients

    Intervention Review

    The Cochrane Library

    Sunil V Badve, Elaine M Beller, Alan Cass, Daniel P Francis, Carmel Hawley, Iain C Macdougall, Vlado Perkovic and David W Johnson

    Published Online : 26 AUG 2013, DOI: 10.1002/14651858.CD006861.pub3

  3. You have free access to this content
    Erythropoietin and iron therapy in patients with renal failure

    Transfusion Alternatives in Transfusion Medicine

    Volume 11, Issue 1, March 2010, Pages: 20–29, LUCIA DEL VECCHIO and FRANCESCO LOCATELLI

    Version of Record online : 16 OCT 2009, DOI: 10.1111/j.1778-428X.2009.01117.x

  4. Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 10, October 2015, Pages: 1068–1075, Marit M. Suttorp, Tiny Hoekstra, Moshe Mittelman, Ilka Ott, Raymond T. Krediet, Friedo W. Dekker and Hein Putter

    Version of Record online : 12 AUG 2015, DOI: 10.1002/pds.3855

  5. You have free access to this content
    Between subjects variability in haemoglobin and dose are not associated with the erythropoiesis-stimulating agent used to treat anaemia in dialysis: a meta-analysis

    British Journal of Clinical Pharmacology

    Volume 75, Issue 1, January 2013, Pages: 15–25, Juan José Pérez-Ruixo, Mercedes Cucala-Ramos, Ester García-Gonzalo, Beatriz Del Val Romero and Neus Valveny

    Version of Record online : 14 DEC 2012, DOI: 10.1111/j.1365-2125.2012.04383.x

  6. Parenteral versus oral iron therapy for adults and children with chronic kidney disease

    Intervention Review

    The Cochrane Library

    Jumana Albaramki, Elisabeth M Hodson, Jonathan C Craig and Angela C Webster

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD007857.pub2

  7. You have free access to this content
    Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin

    American Journal of Hematology

    Volume 87, Issue 8, August 2012, Pages: 833–836, Anuja Shah, Miklos Z. Molnar, Lilia R. Lukowsky, Joshua J. Zaritsky, Csaba P. Kovesdy and Kamyar Kalantar-Zadeh

    Version of Record online : 28 MAY 2012, DOI: 10.1002/ajh.23255

  8. You have full text access to this OnlineOpen article
    Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 4, April 2015, Pages: 414–426, Iain A. Gillespie, Iain C. Macdougall, Sharon Richards, Vincent Jones, Daniele Marcelli, Marc Froissart, Kai-Uwe Eckardt and on behalf of the ARO Steering Committee

    Version of Record online : 17 FEB 2015, DOI: 10.1002/pds.3755

  9. Hemoglobin Control, ESA Resistance, and Regular Low-Dose IV Iron Therapy: A Review of the Evidence

    Seminars in Dialysis

    Volume 22, Issue 1, January/February 2009, Pages: 64–69, Ajay Singh

    Version of Record online : 12 DEC 2008, DOI: 10.1111/j.1525-139X.2008.00518.x

  10. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia

    Hemodialysis International

    Volume 18, Issue 4, October 2014, Pages: 740–750, Sandawana William Majoni, Joy-Anne Ellis, Heather Hall, Asanga Abeyaratne and Paul D. Lawton

    Version of Record online : 27 APR 2014, DOI: 10.1111/hdi.12173


    Journal of Renal Care

    Volume 38, Issue 4, December 2012, Pages: 191–201, Josephine Sau Fan Chow, Glenda Rayment, Veronica Britos, Bruce Cleland and Michael Suranyi

    Version of Record online : 25 AUG 2012, DOI: 10.1111/j.1755-6686.2012.00318.x

  12. You have full text access to this OnlineOpen article
    TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients

    Hemodialysis International

    Volume 18, Issue 1, January 2014, Pages: 38–46, Adam E. Gaweda, Premila Bhat, Gregory A. Maglinte, Chun-Lan Chang, Jerrold Hill, Grace S. Park, Akhtar Ashfaq and Matthew Gitlin

    Version of Record online : 22 AUG 2013, DOI: 10.1111/hdi.12078

  13. 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

    Therapeutic Apheresis and Dialysis

    Volume 14, Issue 3, June 2010, Pages: 240–275, Yoshiharu Tsubakihara, Shinichi Nishi, Takashi Akiba, Hideki Hirakata, Kunitoshi Iseki, Minoru Kubota, Satoru Kuriyama, Yasuhiro Komatsu, Masashi Suzuki, Shigeru Nakai, Motoshi Hattori, Tetsuya Babazono, Makoto Hiramatsu, Hiroyasu Yamamoto, Masami Bessho and Tadao Akizawa

    Version of Record online : 25 MAY 2010, DOI: 10.1111/j.1744-9987.2010.00836.x

  14. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication

    Statistics in Medicine

    Volume 34, Issue 7, 30 March 2015, Pages: 1150–1168, Yun Li, Yoonseok Lee, Robert A. Wolfe, Hal Morgenstern, Jinyao Zhang, Friedrich K. Port and Bruce M. Robinson

    Version of Record online : 29 DEC 2014, DOI: 10.1002/sim.6404

  15. Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients

    Clinical Transplantation

    Volume 26, Issue 5, September/October 2012, Pages: 782–791, Miklos Z. Molnar, Csaba P. Kovesdy, Laszlo Rosivall, Suphamai Bunnapradist, Junichi Hoshino, Elani Streja, Mahesh Krishnan and Kamyar Kalantar-Zadeh

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1399-0012.2012.01598.x

  16. Lisinopril pharmacokinetics and erythropoietin requirement in haemodialysis patients

    European Journal of Clinical Investigation

    Volume 42, Issue 10, October 2012, Pages: 1087–1093, Wolfgang Winnicki, Anna Prehslauer, Josef Kletzmayr, Harald Herkner, Gere Sunder-Plassmann, Martin Brunner, Walter H. Hörl and Guerkan Sengoelge

    Version of Record online : 28 JUL 2012, DOI: 10.1111/j.1365-2362.2012.02699.x

  17. Anemia and Iron Management

    Seminars in Dialysis

    Volume 24, Issue 5, September/October 2011, Pages: 498–503, Anatole Besarab

    Version of Record online : 9 SEP 2011, DOI: 10.1111/j.1525-139X.2011.00983.x

  18. How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients?

    Seminars in Dialysis

    Volume 26, Issue 5, September–October 2013, Pages: 537–540, Marisa Battistella and Christopher T Chan

    Version of Record online : 5 JUN 2013, DOI: 10.1111/sdi.12106

  19. The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure

    Hemodialysis International

    Volume 20, Issue 3, July 2016, Pages: 392–398, Yossi Chait, Sahir Kalim, Joseph Horowitz, Christopher V. Hollot, Elizabeth D. Ankers, Michael J. Germain and Ravi I. Thadhani

    Version of Record online : 3 FEB 2016, DOI: 10.1111/hdi.12407

  20. ITACA: A New Validated International Erythropoietic Stimulating Agent-Response Score that Further Refines the Predictive Power of Previous Scoring Systems

    American Journal of Hematology

    Accepted manuscript online: 4 JUL 2017, Rena Buckstein, Enrico Balleari, Richard Wells, Valeria Santini, Alessandro Sanna, Chiara Salvetti, Elena Crisà, Bernardino Allione, Paolo Danise, Carlo Finelli, Marino Clavio, Antonella Poloni, Flavia Salvi, Daniela Cilloni, Esther Natalie Oliva, Pellegrino Musto, Brett Houston, Nancy Zhu, Michelle Geddes, Heather Leitch, Brian Leber, Mitchell Sabloff, Thomas J. Nevill, Karen Yee, John M. Storring, Janika Francis, Luca Maurillo, Roberto Latagliata, Maria Antonietta Aloe Spiriti, Alessandro Andriani, Anna Lina Piccioni, Luana Fianchi, Susanna Fenu, Svitlana Gumenyuk and Francesco Buccisano

    DOI: 10.1002/ajh.24842